 |
市場調查報告書
商品編碼
1747498
鬱血性心臟衰竭：按類型、按診斷、按性別、按年齡層、按最終用戶、按地區Congestive Heart Failure Market, By Type, By Diagnosis, By Gender, By Age Group, By End User, By Geography |
||||||
價格
簡介目錄
2025 年全球鬱血性心臟衰竭市場規模估計為 249.5 億美元，預計到 2032 年將達到 408.5 億美元，2025 年至 2032 年的複合年成長率為 7.3%。
| 報告範圍 | 報告詳細資訊 | ||
|---|---|---|---|
| 基準年 | 2024 | 2025年的市場規模 | 249.5億美元 |
| 效能數據 | 從2020年到2024年 | 預測期 | 2025年至2032年 |
| 預測期：2025-2032年複合年成長率： | 7.30% | 2032年價值預測 | 408.5億美元 |
近年來，受心血管疾病患病率上升、老年人口成長以及對有效治療方案需求不斷成長的推動，全球鬱血性心臟衰竭市場經歷了顯著成長。鬱血性心臟衰竭衰竭(CHF) 是一種慢性疾病，其特徵是心臟無法泵出足夠的血液來滿足身體需求。先進診斷技術和創新治療方法的出現顯著擴展了充血性心臟衰竭管理市場。
市場動態：
全球鬱血性心臟衰竭市場受到多種因素驅動，包括心血管疾病盛行率上升、老年人口成長以及久坐不動的生活方式日益增加。此外，人們越來越意識到早期診斷和治療鬱血性心臟衰竭的重要性，這也促進了市場的成長。然而，一些地區治療費用高昂且報銷政策不佳可能會抑制市場成長。此外，一些現有治療方案的副作用也可能阻礙市場成長。另一方面，基因治療和幹細胞治療等新型治療方法的開發以及對個人化醫療的日益關注，為市場相關人員提供了巨大的成長機會。此外，製藥公司和研究機構之間在新型療法開發方面加強合作，預計也將在未來幾年推動市場發展。
本研究的主要特點
- 本報告對全球鬱血性心臟衰竭市場進行了詳細分析，並提供了預測期（2025-2032 年）的市場規模（十億美元）和年複合成長率（CAGR%），假設基準年為 2024 年。
- 它還強調了各個領域的潛在商機，並說明了該市場的有吸引力的投資提案矩陣。
- 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
- 它根據公司亮點、產品系列、關鍵亮點、財務表現和策略等參數，介紹了全球鬱血性心臟衰竭市場的主要企業概況。
- 本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
- 全球鬱血性心臟衰竭市場報告針對該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。
- 相關人員將透過用於分析全球鬱血性心臟衰竭市場的各種策略矩陣更輕鬆地做出決策。
目錄
第1章 調查目的與前提條件
- 研究目標
- 先決條件
- 簡稱
第2章 市場展望
- 報告描述
- 市場定義和範圍
- 執行摘要
第3章市場動態、法規與趨勢分析
- 市場動態
- 驅動程式
- 限制因素
- 機會
- 影響分析
- 主要進展
- 監管情景
- 產品發布/核准
- PEST分析
- 波特分析
- 併購場景
- 產業趨勢
4. 2020 年至 2032 年全球鬱血性心臟衰竭市場（按類型）
- 收縮性心臟衰竭衰竭
- 舒張性心衰竭
- 急性心臟衰竭
- 慢性心臟衰竭衰竭
5. 全球鬱血性心臟衰竭市場（依診斷），2020 年至 2032 年
- 心臟超音波圖
- 胸部X光檢查
- 血液檢測（BNP、NT-proBNP）
- 心導管檢查
- 磁振造影
- 動態心電圖監測儀
- 核子造影
6. 2020 年至 2032 年全球鬱血性心臟衰竭市場（以設備類型）
- 心律調節器
- 植入式心臟整流去顫器（ICD）
- 心臟再同步治療 (CRT) 設備
- 心室輔助裝置（VAD）
- 遠端監控設備
- 其他
7. 2020 年至 2032 年全球鬱血性心臟衰竭（依性別分類）
- 男性
- 女士
8. 2020 年至 2032 年按年齡分類的全球鬱血性心臟衰竭市場
- 成人
- 孩子們
- 老年人
9. 2020 年至 2032 年全球鬱血性心臟衰竭市場（依最終用戶分類）
- 醫院
- 專科診所
- 門診手術中心
- 診斷中心
- 家庭醫療保健
- 學術研究所
第 10 章。 2020 年至 2032 年按地區分類的全球鬱血性心臟衰竭市場
- 北美洲
- 美國
- 加拿大
- 拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲
- 歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
- 亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太地區
- 中東
- 海灣合作理事會國家
- 以色列
- 其他中東地區
- 非洲
- 南非
- 北非
- 中部非洲
第11章競爭格局
- Novartis
- Boehringer Ingelheim
- AstraZeneca
- Johnson & Johnson
- Abbott
- Medtronic
- Boston Scientific
- Pfizer
- Merck & Co
- Bristol Myers Squibb
- LivaNova
- Biotronik
- V-Wave
- Impulse Dynamics
- CVRx
第 12 章分析師建議
- 機會
- 分析師觀點
- Coherent Opportunity Map
第13章參考文獻與調查方法
- 參考
- 調查方法
- 關於出版商
簡介目錄
Product Code: CMI7922
Global Congestive Heart Failure Market is estimated to be valued at USD 24.95 Bn in 2025 and is expected to reach USD 40.85 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.3% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 24.95 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 7.30% | 2032 Value Projection: | USD 40.85 Bn |
The global congestive heart failure market has witnessed significant growth in recent years, driven by the increasing prevalence of cardiovascular diseases, the rising geriatric population, and the growing demand for effective treatment options. Congestive heart failure (CHF) is a chronic condition characterized by the heart's inability to pump sufficient blood to meet the body's needs. With the advent of advanced diagnostic techniques and innovative treatment approaches, the market for CHF management has expanded considerably.
Market Dynamic:
The global congestive heart failure market is driven by several factors, including the rising prevalence of cardiovascular diseases, the growing geriatric population, and the increasing adoption of sedentary lifestyles. The increasing awareness about the importance of early diagnosis and treatment of CHF have also contributed to the market growth. However, the high cost of treatment and the lack of reimbursement policies in some regions may restrain the market growth. Moreover, the side effects associated with some of the available treatment options may also hinder the market growth. On the other hand, the development of novel therapies, such as gene therapy and stem cell therapy, and the increasing focus on personalized medicine offer significant growth opportunities for the market players. Increasing collaborations between pharmaceutical companies and research institutes for the development of novel therapies are also expected to drive the market growth in the coming years.
Key Features of the Study:
- This report provides in-depth analysis of the global congestive heart failure market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global congestive heart failure market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Novartis, Boehringer Ingelheim, AstraZeneca, Johnson & Johnson, Abbott, Medtronic, Boston Scientific, Pfizer, Merck & Co, Bristol Myers Squibb, LivaNova, Biotronik, V-Wave, Impulse Dynamics, and CVRx
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global congestive heart failure market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global congestive heart failure market
Market Segmentation
- Type Insights (Revenue, USD Bn, 2020 - 2032)
- Systolic Heart Failure
- Diastolic Heart Failure
- Acute Heart Failure
- Chronic Heart Failure
- Diagnosis Insights (Revenue, USD Bn, 2020 - 2032)
- Echocardiography
- Chest X-Ray
- Blood Tests (BNP, NT-proBNP)
- Cardiac Catheterization
- Magnetic Resonance Imaging
- Holter Monitoring
- Nuclear Imaging
- Device Type Insights (Revenue, USD Bn, 2020 - 2032)
- Pacemakers
- Implantable Cardioverter-Defibrillators (ICDs)
- Cardiac Resynchronization Therapy (CRT) Devices
- Ventricular Assist Devices (VADs)
- Remote Monitoring Devices
- Others
- Gender Insights (Revenue, USD Bn, 2020 - 2032)
- Male
- Female
- Age Group Insights (Revenue, USD Bn, 2020 - 2032)
- Adult
- Pediatrics
- Geriatric
- End User Insights (Revenue, USD Bn, 2020 - 2032)
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
- Diagnostic Centers
- Home Healthcare
- Academic and Research Institutes
- Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Novartis
- Boehringer Ingelheim
- AstraZeneca
- Johnson & Johnson
- Abbott
- Medtronic
- Boston Scientific
- Pfizer
- Merck & Co
- Bristol Myers Squibb
- LivaNova
- Biotronik
- V-Wave
- Impulse Dynamics
- CVRx
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Congestive Heart Failure Market, By Type
- Global Congestive Heart Failure Market, By Diagnosis
- Global Congestive Heart Failure Market, By Device Type
- Global Congestive Heart Failure Market, By Gender
- Global Congestive Heart Failure Market, By Age Group
- Global Congestive Heart Failure Market, By End User
- Global Congestive Heart Failure Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Congestive Heart Failure Market, By Type, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Systolic Heart Failure
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Diastolic Heart Failure
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Acute Heart Failure
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Chronic Heart Failure
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
5. Global Congestive Heart Failure Market, By Diagnosis, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Echocardiography
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Chest X-Ray
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Blood Tests (BNP, NT-proBNP)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Cardiac Catheterization
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Magnetic Resonance Imaging
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Holter Monitoring
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Nuclear Imaging
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Congestive Heart Failure Market, By Device Type, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Pacemakers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Implantable Cardioverter-Defibrillators (ICDs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Cardiac Resynchronization Therapy (CRT) Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Ventricular Assist Devices (VADs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Remote Monitoring Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Congestive Heart Failure Market, By Gender, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Male
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Female
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Congestive Heart Failure Market, By Age Group, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Pediatrics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Geriatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
9. Global Congestive Heart Failure Market, By End User, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Diagnostic Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Home Healthcare
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
10. Global Congestive Heart Failure Market, By Region, 2020 - 2032, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Diagnosis, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Device Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Diagnosis, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Device Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Diagnosis, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Device Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Diagnosis, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Device Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Diagnosis, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Device Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Diagnosis, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Device Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
11. Competitive Landscape
- Novartis
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Boehringer Ingelheim
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AstraZeneca
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Abbott
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Medtronic
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Boston Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Pfizer
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck & Co
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bristol Myers Squibb
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- LivaNova
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Biotronik
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- V-Wave
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Impulse Dynamics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- CVRx
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
12. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
13. References and Research Methodology
- References
- Research Methodology
- About us
02-2729-4219
+886-2-2729-4219
鬱血性心臟衰竭市場：按治療類型、疾病類型、最終用戶和交付方式 - 2025-2030 年全球預測
2025-2033 年充血性心臟衰竭藥物市場（依藥物類別、給藥途徑、配銷通路及地區分類）
鬱血性心臟衰竭藥物市場規模、佔有率、趨勢分析報告：按藥物、產品、通路、地區、細分市場預測，2024-2030年
充血性心臟衰竭 (CHF) 市場 - 成長、未來前景、競爭分析，2023-2031 年
充血性心臟衰竭藥物市場，按類型、藥物類別、分銷管道、國家和地區 - 2023-2030 年行業分析、市場規模、市場佔有率和預測
全球充血性心臟衰竭藥物市場研究報告 - 2023 年至 2030 年行業分析、規模、佔有率、成長、趨勢和預測